Aliases & Classifications for Color Blindness

About this section

Aliases & Descriptions for Color Blindness:

Name: Color Blindness 10 47 12 35 65
Colour Vision Deficiency 10
 
Colour Blindness 10
Blindness Color 10

Classifications:



External Ids:

Disease Ontology10 DOID:13399
ICD1027 H53.5, H53.50
ICD9CM29 368.5
MeSH36 D003117
NCIt42 C3891
UMLS65 C0242225

Summaries for Color Blindness

About this section
MedlinePlus:35 Most of us see our world in color. we enjoy looking at a lush green lawn or a red rose in full bloom. if you have a color vision defect, you may see these colors differently than most people. there are three main kinds of color vision defects. red-green color vision defects are the most common. this type occurs in men more than in women. the other major types are blue-yellow color vision defects and a complete absence of color vision. most of the time, color blindness is genetic. there is no treatment, but most people adjust and the condition doesn't limit their activities.

MalaCards based summary: Color Blindness, also known as colour vision deficiency, is related to red color blindness and colorblindness, deutan. An important gene associated with Color Blindness is OPN1SW (Opsin 1 (Cone Pigments), Short-Wave-Sensitive), and among its related pathways are Metabolism of fat-soluble vitamins and Diseases associated with visual transduction. Affiliated tissues include eye, endothelial and brain, and related mouse phenotype vision/eye.

Disease Ontology:10 A blindness that is characterized by the inability or decreased ability to see color, or perceive color differences, under normal lighting conditions.

Wikipedia:68 Color blindness, or color vision deficiency, is the inability or decreased ability to see color, or... more...

Related Diseases for Color Blindness

About this section

Diseases in the Color Blindness family:

Acquired Color Blindness

Diseases related to Color Blindness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 168)
idRelated DiseaseScoreTop Affiliating Genes
1red color blindness33.9CNGB3, OPN1MW
2colorblindness, deutan31.9CNGA3, CNGB3, OPN1LW, OPN1MW
3blue color blindness12.7
4red-green color blindness12.6
5acquired color blindness12.5
6achromatopsia12.1
7blue cone monochromacy12.0
8colorblindness, tritan11.9
9color vision deficiency11.9
10red-green color vision defects11.6
11paragangliomas 1, with or without deafness11.5
12colorblindness, protan11.5
13achromatopsia 710.2
14hypogonadotropic hypogonadism 1 with or without anosmia10.2
15waisman syndrome10.2OPN1LW, OPN1MW
16hiv-110.2
17endotheliitis10.2
18riboflavin transporter deficiency neuronopathy10.1OPN1LW, OPN1MW
19nephrosclerosis10.1CNGB3, OPN1SW
20myocardial infarction10.1
21asthma10.1
22hepatitis c virus10.1
23cataract10.1
24gastric cancer10.1
25hepatitis10.1
26leukemia10.1
27lymphoma10.1
28hepatitis c10.1
29ischemia10.1
30neuronitis10.1
31encephalopathy10.1
32schizophrenia9.9
33colorectal cancer9.9
34lung cancer9.9
35prostate cancer9.9
36hepatocellular carcinoma9.9
37breast cancer9.9
38renal cell carcinoma9.9
39wolf-hirschhorn syndrome9.9
40attention deficit-hyperactivity disorder9.9
41cystic fibrosis9.9
42werner syndrome9.9
43preterm premature rupture of the membranes9.9
44hypertriglyceridemia9.9
45aspergillosis9.9
46trichotillomania9.9
47nasopharyngeal carcinoma9.9
48becker muscular dystrophy9.9
49pulmonary hypertension9.9
50acute myocardial infarction9.9

Graphical network of the top 20 diseases related to Color Blindness:



Diseases related to color blindness

Symptoms for Color Blindness

About this section

Drugs & Therapeutics for Color Blindness

About this section

Drugs for Color Blindness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RanibizumabapprovedPhase 4460347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
2Angiogenesis InhibitorsPhase 43688
3Angiogenesis Modulating AgentsPhase 43611
4Immunologic FactorsPhase 418483
5
Valproic Acidapproved, investigationalPhase 231199-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
6Tranquilizing AgentsPhase 23597
7Psychotropic DrugsPhase 25501
8Antimanic AgentsPhase 2663
9AnticonvulsantsPhase 22249
10Central Nervous System DepressantsPhase 210016
11Neurotransmitter AgentsPhase 2, Phase 114795
12
ClemastineapprovedPhase 1815686-51-826987
Synonyms:
(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
(+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine
(+)-(2R)-2-[2-[[(R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine
(2R)-2-(2-{[(1R)-1-(4-chlorophenyl)-1-phenylethyl]oxy}ethyl)-1-methylpyrrolidine
(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
(2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine
14976-57-9
15686-51-8
2(R)-[2-[(1R)-(4-Chlorophenyl)-1-phenyl-ethoxy]ethyl-1-methylpyrrolidine
2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin
AC1L1CAE
AC1Q3N52
BIDD:GT0391
BPBio1_000300
BRD-K30240666-051-05-0
BSPBio_000272
BSPBio_002045
C21H26ClNO
CAS-14976-57-9
CHEBI:3738
CHEMBL1626
CID26987
CLEMASTINE FUMARATE
Clemastina
Clemastina [INN-Spanish]
Clemastine
Clemastine Fumarate
Clemastine [USAN:BAN]
Clemastine fumarate
Clemastinum
Clemastinum [INN-Latin]
 
DB00283
DivK1c_000285
HMS2089I22
HS 592
HS-592
IDI1_000285
KBio1_000285
KBio3_001265
KBioGR_001570
LS-137531
Lopac-C-8903
Meclastin
Meclastine
Mecloprodin
NCGC00015281-01
NCGC00016710-01
NCGC00025168-01
NINDS_000285
Prestwick0_000306
Prestwick1_000306
Prestwick2_000306
Prestwick3_000306
SPBio_000817
SPBio_002491
Spectrum2_000689
Spectrum3_000353
Spectrum4_000955
Spectrum5_001520
Tavegyl
Tavist
Tavist (*Fumarate*)
Tocris-1453
UNII-95QN29S1ID
clemastine
13
Histamine PhosphateapprovedPhase 190651-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
 
H0147
Histamine Positive Skin Test Control
Histamine Positive skin test control
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
14Histamine H1 AntagonistsPhase 1688
15AntipruriticsPhase 1619
16Histamine AntagonistsPhase 1826
17Anti-Allergic AgentsPhase 11312
18
histaminePhase 190675614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
19Dermatologic AgentsPhase 14555
20
Latanoprostapproved, investigational184130209-82-45282380, 5311221
Synonyms:
130209-82-4
AC1NSK8Q
AR-202
Ambap130209-82-4
CHEBI:6384
CHEMBL1051
CID5311221
CPD000466354
Catioprost
D00356
HMS2051H11
HMS2089J17
Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate
Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Jsp001835
L1167_SIGMA
Latanoprost
Latanoprost (JAN/USAN/INN)
Latanoprostum
MLS000759468
MLS001424106
 
MolPort-003-942-862
Nova-21027
PHXA-41
PhXA 41
PhXA34 [as 15(R,S)-isomer]
PhXA41
Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
S1254_Selleck
SAM001246671
SMR000466354
TL8000716
XA-41
XA41
Xalatan
Xalatan (TN)
Xalatan Fixed Flow Device
ZINC12468792
isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
latanoprost
latanoprost free acid
propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
21
Timololapproved23626839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
NCGC00016038-02
 
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol hemihydrate
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptic-xe
Timoptol
Tocris-0649
UNII-817W3C6175
timolol
22
Epinephrineapproved83451-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine bitartrate
Epinephrine chloride
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr
Epipen Jr.
Epipen Jr. Auto-Injector
Epipen jr
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
 
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
Primatene Mist Refill
Prime Asthma Relief
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
23
Bevacizumabapproved, investigational1875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
24
Luteinapproved, nutraceutical69127-40-25368396, 6433159
Synonyms:
(3R,3'R)-beta,beta-Carotene-3,3'-Diol, Lutein
(3R,3'R,6'R)-Lutein
(3R,3'R,6S)-4,5-Didehydro-5,6-Dihydro-beta,beta-Carotene-3,3'-Diol
3,3'-Dihydroxy-alpha-carotene
4,5-Didehydro-5,6-dihydro-beta,beta-carotene-3,3'-diol
All-trans-(+)-Xanthophyll
All-trans-Lutein
All-trans-Xanthophyll
 
Bo-Xan
Lutein
Lutein ester
Luteine
Phylloxanthin
SID548587
Vegetable lutein
Vegetable luteol
beta,epsilon-Carotene-3,3'-diol
trans-Lutein
25Adrenergic beta-Antagonists979
26Anti-Arrhythmia Agents2371
27Brimonidine Tartrate11670359-46-5
28Adrenergic Antagonists1253
29Antihypertensive Agents3618
30Epinephryl borate834
31Racepinephrine834
32Adrenergic alpha-Agonists1300
33Adrenergic Agents4204
34Adrenergic Agonists2331
35Adrenergic alpha-2 Receptor Agonists790
36Mitogens1386
37Endothelial Growth Factors328
38BlueberryNutraceutical52
39AnthocyanidinNutraceutical71
40CitrateNutraceutical1001
41
Citric Acidnutraceutical100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid

Interventional clinical trials:

(show all 24)
idNameStatusNCT IDPhase
1Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisNot yet recruitingNCT01669447Phase 4
2Trial of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01233609Phase 2
3Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked AchromatopsiaRecruitingNCT02610582Phase 1, Phase 2
4Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 AchromatopsiaRecruitingNCT02599922Phase 1, Phase 2
5CNTF Implants for CNGB3 AchromatopsiaActive, not recruitingNCT01648452Phase 1, Phase 2
6Effect of Clemastine Fumarate on Color Vision in Healthy ControlsRecruitingNCT02613091Phase 1
7Ì-SPIES, Comparison of Cystoscopy Images in Four Different SPIES ModalitiesCompletedNCT02174302
8Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal DystrophyCompletedNCT00422721
9Blueberry Effects on Dark Vision and Glare RecoveryCompletedNCT01942746
10Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT00706927
11Study of the Macular Pigment by the Consumption of Corn With Strong Content in ZeaxanthineCompletedNCT02113254
12Ocular Blood Flow in Glaucoma Patients - the Leuven Eye StudyCompletedNCT01840202
13VERION Versus Conventional, Manual Ink-marking in Toric IOL ImplantationCompletedNCT02370953
14Study of Usher Syndromes, Type 1 and Type 2CompletedNCT00001347
15Evaluating Color Perception Under LED Red/Green and Green Dominant LightRecruitingNCT01927536
16Evaluation of Different Color Vision Tests in ChildrenRecruitingNCT02464241
17Do Blue-Blocking Lenses Block Blue Colour From Our Lives?RecruitingNCT00403143
18Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)RecruitingNCT02173496
19Panretinal Photo-stimulation in Proliferative Diabetic RetinopathyRecruitingNCT02309502
20Non-invasive Optical Angiography in Age-related Macular DegenerationRecruitingNCT02521142
21Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)RecruitingNCT02762188
22Clinical and Genetic Characterization of Individuals With AchromatopsiaActive, not recruitingNCT01846052
23The Role of Macular Pigment in Patients With Age-related Macular DegenerationActive, not recruitingNCT00494325
24Risk Factors for Drusen ProgressionWithdrawnNCT01830608

Search NIH Clinical Center for Color Blindness

Genetic Tests for Color Blindness

About this section

Anatomical Context for Color Blindness

About this section

MalaCards organs/tissues related to Color Blindness:

33
Eye, Endothelial, Brain, Heart, Testes, Lung, Breast

Animal Models for Color Blindness or affiliated genes

About this section

MGI Mouse Phenotypes related to Color Blindness:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053917.0CNGA3, CNGB3, CNNM4, GNAT2, OPN1LW, OPN1SW

Publications for Color Blindness

About this section

Articles related to Color Blindness:

(show top 50)    (show all 188)
idTitleAuthorsYear
1
Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold. (26633727)
2016
2
A Case-controlled Investigation of Pain Experience and Sensory Function in Neuronal Ceroid Lipofuscinosis. (25569218)
2015
3
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. (23455361)
2014
4
Postexercise syncope: Wingate syncope test and effective countermeasure. (24078670)
2014
5
Septic shock and necrotizing fasciitis due to Aeromonas hydrophila after chemotherapy in a patient with mantle cell lymphoma accompanied by liver cirrhosis. (25744046)
2014
6
Primary headache disorders in children under 7 years of age. (23596025)
2013
7
Mesenchymal stem cells overexpressing PEDF decrease the angiogenesis of gliomas. (22917444)
2013
8
A novel approach for measuring the burden of uncomplicated Plasmodium falciparum malaria: application to data from Zambia. (23468961)
2013
9
TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. (23447579)
2013
10
Hemodialysis-associated acute systemic reactions and heparin-induced thrombocytopenia. (22127211)
2012
11
A case of diffuse neuronal hypertrophy in acute appendicitis. (23113855)
2012
12
Recent incidence of type 1 diabetes mellitus in children 0-14 years in Newfoundland and Labrador, Canada climbs to over 45/100,000: a retrospective time trend study. (23146327)
2012
13
Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. (21607620)
2012
14
Cerebral malaria: mysteries at the blood-brain barrier. (22460644)
2012
15
Different SNP combinations in the GCH1 gene and use of labor analgesia. (20633294)
2010
16
A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation. (20028734)
2010
17
Possible interaction between topical terbinafine and acenocoumarol. (19843835)
2009
18
Apparent third patient with cutaneous mastocytosis, microcephaly, conductive hearing loss, and microtia. (19764024)
2009
19
Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiation. (18701445)
2009
20
Mutation analysis of CRYAA, CRYGC, and CRYGD associated with autosomal dominant congenital cataract in Brazilian families. (19390652)
2009
21
Population-based estimates of whiplash injury using nass cds data - biomed 2009. (19369770)
2009
22
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression. (19059880)
2009
23
Development of a novel noncompetitive antagonist of IL-1 receptor. (18453620)
2008
24
Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. (18447713)
2008
25
Teaching NeuroImage: isolated intracranial Rosai-Dorfman disease mimicking a meningioma. (18362277)
2008
26
Therapeutic potential of synchronized gastric electrical stimulation for gastroparesis: enhanced gastric motility in dogs. (17881615)
2007
27
Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. (17578052)
2007
28
Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. (17161479)
2007
29
Stressing out over survival: glutamine as an apoptotic modulator. (16154153)
2006
30
Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. (15651061)
2005
31
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. (15215217)
2004
32
Evaluation of angioarchitecture of pulmonary sequestration in pediatric patients using 3D MDCT angiography. (15208135)
2004
33
Penicilliosis in China. (15518341)
2004
34
Gene expression profile of AIDS-related Kaposi's sarcoma. (12697073)
2003
35
Acute suppurative thyroiditis. (11374641)
2001
36
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. (11704631)
2001
37
Interdomain chaperoning between PSD-95, Dlg, and Zo-1 (PDZ) domains of glutamate receptor-interacting proteins. (11553623)
2001
38
Stat5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity. (10744710)
2000
39
Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase. (9234701)
1997
40
Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression. (9207038)
1997
41
A new type of major aminopeptidase in bovine brain. (8986639)
1996
42
Detection of alpha-thalassemia-2 (-3.7 kb) and its corresponding triplication (alpha)(alpha)(alpha) (anti-3.7 kb) by PCR: an improved technical change. (8895694)
1996
43
The effects of auranofin on activation and interleukin-2 release from human peripheral blood mononuclear cells. (8023745)
1993
44
Inflammation in HLA-B27-associated diseases. (2259884)
1990
45
The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy. (2563321)
1989
46
Geleophysic dysplasia--acromicric dysplasia with evidence of glycoprotein storage. (3130853)
1987
47
Phialophora verrucosa-induced subcutaneous phaeohyphomycosis. Fine needle aspiration findings. (3461651)
1986
48
Aplasia cutis congenita: a cutaneous marker of occult spinal dysraphism. (6987360)
1980
49
Toxic megacolon with perforation. Case report. (4746805)
1973
50
Hypochromic anemia in the aged. (14890306)
1951

Variations for Color Blindness

About this section

Expression for genes affiliated with Color Blindness

About this section
Search GEO for disease gene expression data for Color Blindness.

Pathways for genes affiliated with Color Blindness

About this section

GO Terms for genes affiliated with Color Blindness

About this section

Biological processes related to Color Blindness according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1cellular response to light stimulusGO:007148210.3OPN1LW, OPN1MW
2positive regulation of cytokinesisGO:003246710.3OPN1LW, OPN1MW
3cation transmembrane transportGO:009865510.0CNGA3, CNGB3
4regulation of membrane potentialGO:004239110.0CNGA3, CNGB3
5visual perceptionGO:00076018.9GNAT2, OPN1LW, OPN1MW, OPN1SW
6G-protein coupled receptor signaling pathwayGO:00071868.7GNAT2, OPN1LW, OPN1MW, OPN1SW
7signal transductionGO:00071658.6CNGA3, CNGB3, GNAT2, PDE6C

Molecular functions related to Color Blindness according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cGMP bindingGO:00305539.8CNGA3, CNGB3

Sources for Color Blindness

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet